Skip to content

13F-HR filed by SCOPIA CAPITAL MANAGEMENT LP

SCOPIA CAPITAL MANAGEMENT LP filed this 13F-HR for the quarter ended 2018-12-31, filed 2019-02-14, with 28 holding rows worth $2,947,517,000.

Accession
0000891092-19-001950
Filed
2019-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2018

A holdings report, 28 entries on the cover page, a total value of $2,947,517,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,947,517,000 with VALUE read as thousands by filing date, 13F file number 028-11096. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPIRIT AEROSYSTEMS HLDGS INC848574109COM CL A4,645,750$334,912,000thousands by filing date
VISTRA CORP COM92840M102Stock13,373,518$306,120,000thousands by filing date
ITRON INC COM465741106Stock5,086,532$240,542,000thousands by filing date
JOHNSON CTLS INTL PLC SHSG51502105Stock8,034,412$238,220,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS10,725,642$209,579,000thousands by filing date
JD.COM INC SPON ADS CL A47215P106ADR7,651,273$160,141,000thousands by filing date
EQUITRANS MIDSTREAM CORP NPV294600101COM7,086,893$141,880,000thousands by filing date
RETROPHIN INC761299106COM5,910,853$133,763,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS1,345,198$131,009,000thousands by filing date
NXP SEMICONDUCTORS N V COMN6596X109Stock1,760,765$129,029,000thousands by filing date
QORVO INC COM74736K101Stock2,112,943$128,319,000thousands by filing date
INVESTORS BANCORP, INC.46146L101COMMON STOCK10,833,824$112,672,000thousands by filing date
WAYFAIR INC94419L101CL A1,219,464$109,849,000thousands by filing date
ZOGENIX INC.98978L204Common Stock2,985,834$108,864,000thousands by filing date
ACORDA THERAPEUTICS INC00484M106COM5,491,035$85,550,000thousands by filing date
SPIRIT RLTY CAP INC NEW NPV84860W300COM NEW1,956,456$68,965,000thousands by filing date
CONMED CORP COM207410101Stock969,160$62,220,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM1,626,965$55,837,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock4,618,164$47,567,000thousands by filing date
ENTERCOM COMMUNICATIONS CORP293639100CL A5,888,683$33,624,000thousands by filing date
Y-mAbs Therapeutics Inc984241109Common Stock1,587,566$31,312,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 22,387,336$22,513,000thousands by filing date
ACUITY INC COM00508Y102Stock185,930$21,373,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock870,695$14,924,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM64,961$6,547,000thousands by filing date
FOSSIL GROUP INC34988V106COMMON STOCK395,925$6,228,000thousands by filing date
SPIRIT MTA REIT84861U105COM SHS BEN IN587,940$4,192,000thousands by filing date
MANNKIND CORP COM NEW56400P706Stock1,666,498$1,766,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000891092-19-001950this filing2019-02-14acceptance time not in the bulk data set